Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Kinomatic Launches "Kinect" Unified Web Platform for AI-Driven Orthopaedic Surgical Planning: Kinomatic released Kinect, a modern web-based ecosystem that unifies 3D CT segmentation, AI-guided alignment planning, and concierge communication across any connected device to streamline surgical preparation for joint arthroplasty.
• Nanochon Achieves First Patient Implantation in Chondrograft™ First-in-Human Clinical Trial for Knee Cartilage Restoration: Nanochon announced the successful first surgical case in its clinical study evaluating Chondrograft™, a patented 3D-printed synthetic implant engineered to restore focal articular cartilage defects in the knee.
• Joseph Spine Institute Inaugurates Dedicated Regenerative Therapy Center for Adipose-Derived Biologics and PRP: Joseph Spine Institute launched a specialized regenerative center in Tampa providing autologous adipose cell and PRP therapies to treat degenerative disc and facet pathology without invasive fusion.
• Arthrex Obtains FDA 510(k) Clearance for Bioabsorbable PushLock® Suture Anchors: Arthrex, Inc. received 510(k) clearance (K262357) for its updated Bioabsorbable PushLock® line, advancing knotless fixation for shoulder labral repair and soft tissue reattachment.
• TriMed Secures FDA 510(k) Clearance for Large Compression Screws in Extremity Reconstruction: TriMed, Inc. earned 510(k) clearance (K262344) for its Large Compression Screw system, expanding fixation options for trauma osteotomies and hindfoot arthrodesis.

DAILY ANNOUNCEMENTS BY CATEGORY

Surgical Robotics, AI & Navigation

Kinomatic — Launches "Kinect" Unified Web Platform Powering AI-Driven Orthopaedic Surgical Planning and Workflow

• Summary: Kinomatic officially launched Kinect, a cloud-based unified platform designed to serve as the connective intelligence layer uniting 3D imaging, AI-assisted surgical planning, communication feeds, and surgeon preferences across arthroplasty workflows. Developed from the ground up as an AI-ready web application accessible across any device, Kinect enables orthopaedic surgeons to review pre-operative segmentation, fine-tune alignment strategies, track patient milestones, and seamlessly communicate preferences with concierge surgical engineers.
• Key Details:
  • Device/System Name: Kinect Unified Platform
  • Status: Commercial Launch / Cloud Enterprise Availability
  • Clinical Significance: Consolidates fragmented pre-operative imaging, alignment preferences, and surgical concierge logistics into a cross-device web ecosystem, minimizing friction between surgical planning and intraoperative execution in total joint replacement.
• Original Source: Kinomatic Kinect Platform Launch — OrthoSpineNews

Joint Reconstruction & Cartilage Regeneration

Nanochon — Implants First Patient in Chondrograft™ First-in-Human Clinical Trial for Knee Chondral Defects

• Summary: Nanochon announced the successful surgical treatment of the first patient enrolled in its First-in-Human clinical feasibility study evaluating Chondrograft™, a patented 3D-printed synthetic cartilage implant designed for focal chondral defects of the knee. Performed by Principal Investigator Dr. Juan Osorio, the procedure initiates clinical validation of a biomimetic polymer-nanomaterial scaffold engineered to provide immediate mechanical load-bearing while fostering native hyaline-like cartilage and subchondral bone regeneration.
• Key Details:
  • Device/System Name: Chondrograft™ 3D-Printed Cartilage Implant
  • Status: First-in-Human Clinical Trial Initiation
  • Clinical Significance: Addresses the critical clinical gap between palliative arthroscopic debridement and total knee arthroplasty by providing an off-the-shelf, minimally invasive structural implant capable of immediate weight-bearing and regenerative tissue integration for active patients with focal articular lesions.
• Original Source: Nanochon Chondrograft™ First-in-Human Trial Debut — OrthoSpineNews

Spine & Orthobiologics

Joseph Spine Institute — Launches Regenerative Therapy Center Featuring Autologous Adipose-Derived Cell and PRP Protocols

• Summary: The nationally recognized Joseph Spine Institute in Tampa, Florida, announced the opening of its specialized Regenerative Therapy Center, introducing evidence-guided autologous adipose-derived cell therapies and high-concentration platelet-rich plasma (PRP) treatments for complex spinal disorders. Tailored for patients suffering from degenerative disc disease, facet joint arthropathy, and chronic back pain, the clinical initiative pairs point-of-care cellular harvesting with image-guided fluoroscopic and ultrasound precision delivery to explore biologic alternatives to invasive arthrodesis.
• Key Details:
  • Device/System Name: Autologous Adipose Cell & PRP Spine Protocols
  • Status: Clinical Service Launch / Dedicated Specialized Center
  • Clinical Significance: Delivers structured, point-of-care orthobiologic alternatives for discogenic and posterior column spinal pathology, offering motion-preserving options that may mitigate systemic opioid utilization and delay or prevent surgical spinal fusion.
• Original Source: Joseph Spine Regenerative Therapy Center Launch — OrthoSpineNews

NEW FDA 510(k) & PMA CLEARANCE LISTING (PAST 24–48 HOURS)